📊 Note: Daily ratings and analytics are updated after market close and will be available by 7:00 PM IST.

Details

NameSymbolSector
ALEMBIC PHARMACEUTICALS LIMITEDAPLLTDPharmaceuticals
Open
668.95
High
681.45
Low
665.25
Close
677.05
Volume
58162
Exchange
nse
Time
01-Apr-2026

Outlook

Score:

3.25

Rating:

FAIR

Candlestick Pattern

CandlepatternofAlembicPharmaceuticalsis
None
EstimatedStoplossofAlembicPharmaceuticalsis
665.25
AlembicPharmaceuticalshasa
Bullishℹ
pattern.
Formationof
None
candlepatternindicatesthetrenddirectionofAlembicPharmaceuticalsis
Unpredictableℹ
.

Trend

AlembicPharmaceuticalsisin
Sideways trendℹ
.
PriceofAlembicPharmaceuticalsis
Downℹ
by

6.42

%.
Target
Buy@

645.23

Sell@

856.03

Current@

677.05

Volume

ThetradevolumesofAlembicPharmaceuticalshavebecome
Deficientℹ
ThevolumetrendforAlembicPharmaceuticalsis
Bearishℹ
,buttheparticipantsare
Weak Sellersℹ
ThetradevolumeofAlembicPharmaceuticalsis

Down

by

23.57

%

Valuation

ThecurrentmarketpriceofAlembicPharmaceuticalsis
Undervaluedℹ

Financials

Balance
Withtotalliablitiesandshareholderequityworth7772crandtotalassetsworth7772cr,thebalancesheetofAlembicPharmaceuticalsis:
Balancedℹ
.
Cashflow
AlembicPharmaceuticalshas
Poorℹ
cashflowbecausethereis

Shortage

of

₹ 36cr

.Itis
Downℹ
by

181.82

%.
7.92% i.e. ₹ 87cr earned in operatingℹ
51.73% i.e. ₹ 568cr spent in investingℹ
40.35% i.e. ₹ 443cr earned in financingℹ
0% in otherℹ
AlembicPharmaceuticalshas
Excellentℹ
cashflowbecausethereis

Surplus

of

₹ 44cr

.Itis
Upℹ
by

214.29

%.
51.47% i.e. ₹ 803cr earned in operatingℹ
20.51% i.e. ₹ 320cr spent in investingℹ
28.01% i.e. ₹ 437cr spent in financingℹ
0% in otherℹ
Income
TheincomeofAlembicPharmaceuticalsis

₹ 1917cr

and

Profit

is:

₹ 182cr

AlembicPharmaceuticalsProfitisupby:

18.18

%andIncomeisUpby:

11.65

%
TheincomeofAlembicPharmaceuticalsis

₹ 1717cr

and

Profit

is:

₹ 154cr

AlembicPharmaceuticalsProfitisdownby:

1.91

%andIncomeisDownby:

3.7

%
TheincomeofAlembicPharmaceuticalsis

₹ 1783cr

and

Profit

is:

₹ 157cr

AlembicPharmaceuticalsProfitisupby:

14.6

%andIncomeisUpby:

4.76

%
By using this site you agree to the use of cookies to deliver a better site experience.